Chronomodulated capecitabine in combination with short-time oxaliplatin: a Nordic phase II study of second-line therapy in patients with metastatic colorectal cancer after failure to irinotecan and 5-flourouracil

Autor: Qvortrup, C. *, Yilmaz, M., Ogreid, D., Berglund, A., Balteskard, L., Ploen, J., Fokstuen, T., Starkhammar, H., Sørbye, H., Tveit, K., Pfeiffer, P.
Zdroj: In Annals of Oncology June 2008 19(6):1154-1159
Databáze: ScienceDirect